Continue reading this on our app for a better experience

Open in App
Floating Button
Home News Company in the news

FJ Benjamin secures distribution rights for UK skincare brand in Singapore, Malaysia and Indonesia

Felicia Tan
Felicia Tan • 2 min read
FJ Benjamin secures distribution rights for UK skincare brand in Singapore, Malaysia and Indonesia
MZ Skin's ultimate age renewal collection. Photo: F J Benjamin
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Catalist-listed FJ Benjamin has clinched the exclusive rights to distribute UK skincare brand, MZ Skin.

The products will be distributed in Singapore, Malaysia and Indonesia, revealed the fashion and lifestyle retailer in its May 31 release.

The distribution agreement will be for an initial two years. It will see MZ Skin products being sold on the retailer’s online platforms and in selected retail outlets.

MZ Skin was launched by London-based oculoplastic surgeon and aesthetic doctor, Dr Maryam Zamani, in 2016 after 15 years of clinical practice.

Zamani is popularly known as ‘the eye doctor’ because of her facial aesthetic skills.

Since its launch, the brand has garnered a global following that includes well-known personalities such as Serena Williams, Sonam Kapoor, Gwyneth Paltrow and Princess Charlene of Monaco.

See also: Sembcorp issues $350 mil of guaranteed notes due 2036 at 3.65%

One of the first physical outlets will be located within Seibu at The Exchange TRX in Kuala Lumpur, Malaysia.

The addition of MZ Skin is part of FJ Benjamin’s strategy to expand its skincare portfolio, says the group.

FJ Benjamin’s chief operating officer Douglas Benjamin says, “MZ Skin’s unique formulations – powered by active ingredients – are based as much on functionality as they are on beauty. We are excited to introduce this highly sought after, innovative and science-based skincare brand to our customers in Southeast Asia.”

See also: Yangzijiang Shipbuilding subsidiaries have ‘reasonably good prospect of success’ in arbitration claims

“FJ Benjamin’s recent diversification into health and wellness has been progressing very smoothly and the plan is to continue to invest in this business particularly as Southeast Asian economies begin to recharge amid a return to normalcy from the Covid-19 pandemic,” he adds.

As at 1.44pm, shares in FJ Benjamin are trading flat at 2.2 cents.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.